Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
Spontaneous reporting systems remain pivotal for post-marketing surveillance and disproportionality analysis (DA) represents a recognized approach for early signal detection. Although DAs cannot be used per se as a standalone approach to assess a drug-related risk and cannot replace clinical judgmen...
Saved in:
| Main Authors: | Paola Maria Cutroneo, Daniele Sartori, Marco Tuccori, Salvatore Crisafulli, Vera Battini, Carla Carnovale, Concetta Rafaniello, Annalisa Capuano, Elisabetta Poluzzi, Ugo Moretti, Emanuel Raschi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-01-01
|
| Series: | Frontiers in Drug Safety and Regulation |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fdsfr.2023.1323057/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline
by: Michele Fusaroli, et al.
Published: (2024-11-01) -
A disproportionality analysis of FDA adverse event reporting system events for misoprostol
by: Li Yang, et al.
Published: (2025-01-01) -
Safety Evaluation of the Combination with Dexrazoxane and Anthracyclines: A Disproportionality Analysis Based on the Food and Drug Administration Adverse Event Reporting System Database
by: Danyi Liu, et al.
Published: (2024-12-01) -
Drug-induced hearing disorders: a disproportionality analysis of the FAERS database
by: Baojian Li, et al.
Published: (2024-11-01) -
Comprehensive safety evaluation of isatuximab in multiple myeloma using disproportionality analysis of FAERS and meta-analysis of randomized controlled trials
by: Muhammed Favas Karimbanathottathil, et al.
Published: (2024-12-01)